Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 117.0	$ 105.3
Trade and other accounts receivable (less allowances of $4.1 million and $4.5 million respectively)	247.9	221.4
Inventories (less allowances of $19.4 million and $19.4 million respectively):
Finished goods	158.5	156.3
Raw materials	64.6	63.7
Total inventories	223.1	220.0
Prepaid expenses	12.3	14.9
Prepaid income taxes	5.0	4.2
Other current assets	2.3	0.4
Total current assets	607.6	566.2
Net property, plant and equipment	209.9	210.8
Operating lease right-of-use assets	36.7	40.1
Goodwill	367.2	371.2
Other intangible assets	70.2	75.3
Deferred tax assets	7.4	7.6
Pension asset	119.6	118.0
Other non-current assets	7.5	8.2
Total assets	1,426.1	1,397.4
Current liabilities:
Accounts payable	114.5	98.7
Accrued liabilities	131.8	129.8
Current portion of finance leases	0.4	0.5
Current portion of plant closure provisions	6.6	6.6
Current portion of accrued income taxes	8.8	5.5
Current portion of operating lease liabilities	12.2	11.3
Total current liabilities	274.3	252.4
Long-term debt	0.0	0.0
Finance leases, net of current portion	0.0	0.1
Operating lease liabilities, net of current portion	24.6	28.9
Plant closure provisions, net of current portion	51.3	51.9
Accrued income taxes, net of current portion	32.4	32.4
Unrecognized tax benefits	16.0	16.0
Deferred tax liabilities	46.5	46.9
Pension liabilities and post-employment benefits	19.5	20.5
Other non-current liabilities	2.4	3.4
Equity:
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares	0.3	0.3
Additional paid-in capital	337.8	336.1
Treasury stock (4,958,599 and 5,047,278 shares at cost, respectively)	(93.6)	(93.3)
Retained earnings	782.0	758.6
Accumulated other comprehensive loss	(67.9)	(57.3)
Total Innospec stockholders' equity	958.6	944.4
Non-controlling interest	0.5	0.5
Total equity	959.1	944.9
Total liabilities and equity	$ 1,426.1	$ 1,397.4